Relationship between GFR and albuminuria in stage 1 hypertension

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 1, 2013, Pages 59-66

  Palatini, Paolo ^a   Mos, Lucio ^b   Ballerini, Pierferruccio ^b   Mazzer, Adriano ^b   Saladini, Francesca ^a   Bortolazzi, Alessandra ^b   Cozzio, Susanna ^c   Casiglia, Edoardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Town Hospital   (Italy)

^c Town Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALBUMIN; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PATIENT CODING; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; ALBUMINURIA; BLOOD PRESSURE; DISEASE PROGRESSION; EPINEPHRINE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; KIDNEY GLOMERULUS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84872194842     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03470412     Document Type: Article

References (33)

1. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49: 1774-1777, 1996
2. Zoccali C: Overweight, obesity and metabolic alterations in chronic kidney disease. Prilozi 30: 17-31, 2009
3. Palatini P, Mormino P, Dorigatti F, Santonastaso M, Mos L, De Toni R, Winnicki M, Dal Follo M, Biasion T, Garavelli G, Pessina AC; HARVEST Study Group;: Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: The HARVEST. Kidney Int 70: 578-584, 2006
4. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG: Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52: 691-697, 2009
5. Schmieder RE, Veelken R, Gatzka CD, Ruddel H, Schachinger H: Predictors for hypertensive nephropathy: Results of a 6-year follow-up study in essential hypertension. J Hypertens 13: 357-365, 1995
6. Palatini P, Mormino P, Mos L, Mazzer A, Dorigatti F, Zanata G, Longo D, Garbelotto R, De Toni R, Graniero G, Pessina AC; HARVEST Study Group;: Microalbuminuria, renal function and development of sustained hypertension: A longitudinal study in the early stage of hypertension. J Hypertens 23: 175-182, 2005
7. Sartori M, Semplicini A, Siffert W, Mormino P, Mazzer A, Pegoraro F, Mos L, Winnicki M, Palatini P: G-protein beta3-subunit gene 825T allele and hypertension: A longitudinal study in young grade I hypertensives. Hypertension 42: 909-914, 2003
8. Palatini P, Dorigatti F, Roman E, Giovinazzo P, Piccolo D, De Venuto G, Mattarei M, Cozzutti E, Gregori S, Mormino P, Pessina AC: White-coat hypertension: A selection bias? J Hypertens 16: 977-984, 1998
9. Wang Y, Wang QJ: The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: New challenges of the old problem. Arch Intern Med 164: 2126-2134, 2004
10. Palatini P, Graniero GR, Mormino P, Nicolosi L, Mos L, Visentin P, Pessina AC: Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study. Circulation 90: 2870-2876, 1994
11. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-Committee. Blood Press Suppl 1: 9-43, 1999
12. European Society of Hypertension-European Society of Cardiology Guidelines Committee;: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
13. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension;: 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25: 1751-1762, 2007
14. National Kidney Foundation:; K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39[suppl 1]: S46-S75, 2002
15. Mogensen CE: Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46: 201-206, 1986
16. Amin R, Turner C, van Aken S, Bahu TK, Watts A, Lindsell DR, Dalton RN, Dunger DB: The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int 68: 1740-1749, 2005
17. Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, Sattar N, Zukowska-Szczechowska E, Dominiczak AF: Glomerular hyperfiltration: A new marker of metabolic risk. Kidney Int 71: 816-821, 2007
18. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S: Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 27: 1821-1825, 2012
19. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, Pessina AC: Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: Results from the HARVEST study. Hypertension 31: 57-63, 1998
20. Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, Grande JP, Textor SC, Lerman A, Lerman LO: Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol 301: F1078-F1087, 2011
21. Schmieder RE, Veelken R, Schobel H, Dominiak P, Mann JF, Luft FC: Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol 8: 893-900, 1997
22. Tidgren B, Hjemdahl P: Renal responses to mental stress and epinephrine in humans. Am J Physiol 257: F682-F689, 1989
23. Lambertucci L, Di Serio C, Castellani S, Torrini M, Lotti E, Cristofari C, Masotti G, Marchionni N, Ungar A: Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension. Transl Res 157: 348-356, 2011
24. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B: Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 323: 85-93, 2007
25. Kuwabara A, Satoh M, Tomita N, Sasaki T, Kashihara N: Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 53: 2056-2065, 2010
26. Sabatini S, Kurtzman NA: Role of hyperfiltration in the pathogenesis of diabetic nephropathy. In: Advances in Pathogenesis of Diabetic Nephropathy, edited by Prabhakar SS, New York, Nova Science Publishers, Inc., 2011, pp 21-48
27. Brenner BM, Rector FC: The Kidney, Philadelphia, W.B. Saunders Company, 2004, p 911
28. Nankivell BJ: Creatinine clearance and the assessment of renal function. Australian Prescriber 24: 15-17, 2001
29. Palatini P, Pessina AC, Dal Palù C: The Hypertension and Ambulatory Recording Venetia Study (HARVEST): A trial on the predictive value of ambulatory blood pressure monitoring for the development of fixed hypertension in patients with borderline hypertension. High Blood Press 2: 11-18, 1993
30. Frank H, Graf J, Amann-Gassner U, Bratke R, Daniel H, Heemann U, Hauner H: Effect of short-term high-protein compared with normal-protein diets on renal hemodynamics and associated variables in healthy young men. Am J Clin Nutr 90: 1509-1516, 2009
31. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
32. Taal MW, Brenner BM: Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists. Kidney Int 57: 1803-1817, 2000
33. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1986